This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

8 Stocks Under $10 Loved by the Bulls

Stocks in this article: SQNM MOBI GALE SNBC NPSP CSUN AMRS EGLE

NPS Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

NPS Pharmaceuticals (NPSP) is a clinical-stage biopharmaceutical company. NPS Pharma is focused on the development of orphan products for patients with rare gastrointestinal and endocrine disorders and high unmet medical needs. This stock is trading up 7% at $7.26 in recent trading.

Today's Range: $6.77-$7.27

52-Week Range: $4.35-$10.33

Volume: 755,000

Three-Month Average Volume: 672,986

>>5 Stocks Under $10 Poised for Breakouts

From a technical perspective, NPSP is soaring here back above its 50-day moving average of $7.18 with above average volume. This move is now setting NPSP up for a much larger trend higher.

Traders should continue to look for long-biased trades as long as NPSP is trending above its 50-day with strong upside volume flows. I would consider any upside volume day that registers near or above 672,986 shares as bullish. If we continue to see that trend, then look for NPSP to re-test $7.60 and then possibly fill a previous gap back towards $8 to $8.35. This stock has some major overhead resistance at $8.35 to $8.48, so if it were to take those levels out with volume it would be very bullish in the near-term.

On the flipside, I would avoid this stock or look for short-biased trades if it fails to get into that gap, or if it drops back below its 50-day with heavy volume.

6 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs